secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001493152-23-020563
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics amends secured note, extends draw period, draws $500K
-----------------------------------------------------------------------

- Third Amendment extends draw period under secured convertible note to Oct 31, 2023 (or earlier if a Qualified Offering occurs).
- Drew $500,000 on June 7, 2023; repayment due February 14, 2024.
- Amendment waives warrant issuance for prior $4M commitment draws under Second Amendment.
- Extends Reverse Financing Condition deadline for subsidiary Reverse Bioengineering to June 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223020563/0001493152-23-020563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223020563/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer